Follicum files patent application for new topical formulation of FOL-005 for hair loss
Follicum applies for extended patent for its topical formulation - BioStock
Tissue Repair Peptides
Follicum featured in the June issue of The New Yorker: “Is the Age-Old Quest for a Baldness Cure Reaching Its End?”
Follicum receives European patent for the company's peptides for developing first in class diabetes treatments
Follicum takes a step closer to phase III entering 2021 - BioStock
What Hair Loss Treatments Could Look Like in the Future | Allure
Follicum AB reports top-line data from First-in-Man Scalp Study with FOL-005 against hair loss
Market Notice 11/22 – Follicum AB will be delisted after close of the market on February 3, 2022
Follicum collaborates with proDERM for the upcoming Phase IIa clinical trial on patients with hair loss
Follicum receives LUDC post-doc funding for novel diabetes peptide mode of action research
Interview with Alejandra Mørk, new Member of the Board in Follicum
Follicum files international patent application conferring extended protection for the topical formulation of FOL-005 and other
World TB Day: Iconovo's ICOone platform in the spotlight - BioStock
Follicum AB on schedule to present top-line results from the phase IIa study with FOL-005 for hair growth at the end of October
150/19 – Information regarding the rights issue from Follicum AB
Endpoints News article about Follicum
Follicum strengthens its clinical expertise in diabetes as novel peptide candidate approaches clinic - establishes Scientific Ad
Follicum Looking Beyond Hair Loss Treatment - His Hair Clinic
182/18 – Last day of trading in Follicum AB's BTU
Follicum applies for extended patent for its topical formulation - BioStock
